DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $964,116 | +5.6% | 3,886 | +2.2% | 0.67% | +14.6% |
| Q2 2023 | $912,960 | -6.8% | 3,804 | -2.2% | 0.58% | -9.2% |
| Q1 2023 | $979,930 | -6.0% | 3,888 | -1.0% | 0.64% | -11.1% |
| Q4 2022 | $1,042,834 | -0.4% | 3,929 | -3.1% | 0.72% | -7.7% |
| Q3 2022 | $1,047,000 | +0.9% | 4,055 | -1.0% | 0.78% | +286.1% |
| Q2 2022 | $1,038,000 | -27.2% | 4,095 | -15.7% | 0.20% | -13.7% |
| Q1 2022 | $1,425,000 | -23.0% | 4,859 | -13.6% | 0.23% | -17.6% |
| Q4 2021 | $1,850,000 | -56.3% | 5,624 | -59.6% | 0.28% | -48.3% |
| Q3 2021 | $4,238,000 | +317.9% | 13,919 | +268.1% | 0.55% | +238.9% |
| Q2 2021 | $1,014,000 | +17.1% | 3,781 | -1.7% | 0.16% | +5.2% |
| Q1 2021 | $866,000 | -1.4% | 3,846 | -2.7% | 0.15% | -7.8% |
| Q4 2020 | $878,000 | +2.1% | 3,951 | -1.0% | 0.17% | -6.2% |
| Q3 2020 | $860,000 | +21.1% | 3,992 | -0.5% | 0.18% | +16.3% |
| Q2 2020 | $710,000 | +28.6% | 4,012 | +0.7% | 0.15% | +10.1% |
| Q1 2020 | $552,000 | -8.8% | 3,986 | +1.2% | 0.14% | +5.3% |
| Q4 2019 | $605,000 | +6.3% | 3,940 | 0.0% | 0.13% | +1.5% |
| Q3 2019 | $569,000 | -0.2% | 3,940 | -1.3% | 0.13% | +4.8% |
| Q2 2019 | $570,000 | +3.8% | 3,990 | -4.0% | 0.12% | +3.3% |
| Q1 2019 | $549,000 | +22.0% | 4,155 | -4.8% | 0.12% | -57.7% |
| Q4 2018 | $450,000 | -7.4% | 4,365 | -2.4% | 0.28% | +11.4% |
| Q3 2018 | $486,000 | +4.1% | 4,473 | -5.4% | 0.26% | +7.6% |
| Q2 2018 | $467,000 | -2.1% | 4,728 | -2.9% | 0.24% | -3.7% |
| Q1 2018 | $477,000 | +6.0% | 4,871 | +0.4% | 0.25% | +12.3% |
| Q4 2017 | $450,000 | +7.9% | 4,851 | -0.2% | 0.22% | +6.3% |
| Q3 2017 | $417,000 | +0.7% | 4,861 | -0.8% | 0.21% | -0.5% |
| Q2 2017 | $414,000 | +7.3% | 4,901 | +8.5% | 0.21% | +8.9% |
| Q1 2017 | $386,000 | +6.6% | 4,516 | -3.0% | 0.19% | +4.4% |
| Q4 2016 | $362,000 | -2.7% | 4,655 | -1.8% | 0.18% | -13.7% |
| Q3 2016 | $372,000 | -21.8% | 4,742 | +0.6% | 0.21% | -24.6% |
| Q2 2016 | $476,000 | +4.8% | 4,714 | -1.5% | 0.28% | +2.2% |
| Q1 2016 | $454,000 | -41.1% | 4,784 | -42.4% | 0.27% | -40.0% |
| Q4 2015 | $771,000 | +12.4% | 8,304 | +3.1% | 0.46% | +4.1% |
| Q3 2015 | $686,000 | -0.7% | 8,054 | -0.2% | 0.44% | +7.6% |
| Q2 2015 | $691,000 | +11.1% | 8,070 | +10.2% | 0.41% | +11.8% |
| Q1 2015 | $622,000 | -2.2% | 7,324 | -1.3% | 0.36% | -5.2% |
| Q4 2014 | $636,000 | +10.6% | 7,424 | -2.0% | 0.38% | +5.8% |
| Q3 2014 | $575,000 | -5.1% | 7,574 | -1.6% | 0.36% | +0.8% |
| Q2 2014 | $606,000 | +10.0% | 7,696 | +4.8% | 0.36% | +6.8% |
| Q1 2014 | $551,000 | -11.1% | 7,346 | -8.5% | 0.34% | -6.1% |
| Q4 2013 | $620,000 | +9.2% | 8,028 | -2.1% | 0.36% | +0.3% |
| Q3 2013 | $568,000 | +0.7% | 8,198 | -7.9% | 0.36% | -7.2% |
| Q2 2013 | $564,000 | – | 8,905 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |